This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sunstar Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Etsuko Kobayashi: Innovator in Peptide Research
Introduction
Etsuko Kobayashi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of peptide research, particularly in the development of novel compounds with therapeutic potential. Her work focuses on innovations that can impact health and medicine.
Latest Patents
Etsuko Kobayashi holds a patent for "Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof." This patent describes a novel peptide with ACE inhibitory activity, specifically a tripeptide consisting of Leu-Arg-Ala. This innovation has potential applications in managing hypertension and related health issues.
Career Highlights
Kobayashi is associated with Sunstar Inc., where she continues to advance her research in peptide technology. Her work has garnered attention for its potential to improve health outcomes through innovative peptide applications.
Collaborations
Etsuko collaborates with notable colleagues, including Naohisa Shobako and Hirohisa Suidou. These partnerships enhance her research efforts and contribute to the development of new therapeutic solutions.
Conclusion
Etsuko Kobayashi is a trailblazer in peptide research, with a focus on developing innovative solutions for health challenges. Her contributions, particularly her patented work, highlight her role as a key inventor in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile